Showing results (21-30 of 57) with videos related to
Sort By:
Pageof 6
Small (Weinheim an Der Bergstrasse, Germany)|October 20, 2020
A Strategy for Tumor Targeting by Higher-Order Glycan Pattern Recognition: Synthesis and In Vitro and In Vivo Properties of Glycoalbumins Conjugated with Four Different N-Glycan MoleculesIvan Smirnov, Regina Sibgatullina, Sayaka Urano, et al.The Journal of Biological Chemistry|April 18, 2014
Multiple sclerosis autoantigen myelin basic protein escapes control by ubiquitination during proteasomal degradationAlexey Belogurov, Anna Kudriaeva, Ekaterina Kuzina, et al.Journal of Neuropathology and Experimental Neurology|December 14, 2011
Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtypePatricia Goldhoff, Jennifer Clarke, Ivan Smirnov, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Array comparative genomic hybridization identifies genetic subgroups in grade 4 human astrocytomaAnjan Misra, Malgorzata Pellarin, Janice Nigro, et al.Plos One|July 2, 2014
AKT pathway genes define 5 prognostic subgroups in glioblastomaAnna Joy, Archana Ramesh, Ivan Smirnov, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patientsEdward Pan, Malgorzata Pellarin, Emi Holmes, et al.Vaccines|January 8, 2025
Protective Antimicrobial Effect of the Potential Vaccine Created on the Basis of the Structure of the IgA1 Protease from Neisseria meningitidisYuri Prokopenko, Alexei Zinchenko, David Karlinsky, et al.Plos One|September 1, 2012
Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomasJane R Engler, Aaron E Robinson, Ivan Smirnov, et al.Journal of Neuro-Oncology|July 17, 2016
The role of AKT isoforms in glioblastoma: AKT3 delays tumor progressionAnna Joy, Manisha Kapoor, Joseph Georges, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 22, 2016
CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation StudyAlexey Belogurov, Konstantin Zakharov, Yakov Lomakin, et al.Pageof 6